KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Notes Payables (2016 - 2025)

Cvs Health's Notes Payables history spans 16 years, with the latest figure at $1.2 billion for Q3 2025.

  • For the quarter ending Q3 2025, Notes Payables rose 55.88% year-over-year to $1.2 billion, compared with a TTM value of $1.2 billion through Sep 2025, up 55.88%, and an annual FY2024 reading of $2.1 billion, up 959.5% over the prior year.
  • Notes Payables for Q3 2025 was $1.2 billion at Cvs Health, down from $3.0 billion in the prior quarter.
  • The five-year high for Notes Payables was $3.0 billion in Q2 2025, with the low at $200.0 million in Q4 2023.
  • Average Notes Payables over 4 years is $1.4 billion, with a median of $1.2 billion recorded in 2025.
  • Year-over-year, Notes Payables soared 959.5% in 2024 and then plummeted 53.7% in 2025.
  • Tracing CVS's Notes Payables over 4 years: stood at $252.0 million in 2021, then dropped by 20.63% to $200.0 million in 2023, then soared by 959.5% to $2.1 billion in 2024, then crashed by 41.15% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for CVS's Notes Payables are $1.2 billion (Q3 2025), $3.0 billion (Q2 2025), and $1.3 billion (Q1 2025).